Predict your next investment

Adaptate Biotherapeutics company logo
HEALTHCARE | Biotechnology
adaptate.com

See what CB Insights has to offer

Founded Year

2019

Stage

Series A | Alive

Total Raised

$18M

Last Raised

$18M | 7 mos ago

About Adaptate Biotherapeutics

Adaptate Biotherapeutics is a biotechnology company which spun out from GammaDelta Therapeutics in 2019. Adaptate Biotherapeutics is focused on developing therapeutic antibodies to drug targets to modulate the activity of gamma delta T cells. Adaptate Biotherapeutics has received investment from Abingworth and Takeda Pharmaceutical Company Limited with support from King’s College London, the Francis Crick Institute and Cancer Research Technology.

Adaptate Biotherapeutics Headquarter Location

195 Wood Lane

London, England, W12 7FQ,

United Kingdom

Latest Adaptate Biotherapeutics News

Adaptate targeting gamma delta T cells in cancer with $18M series A

Apr 20, 2021

April 19, 2021 LONDON – Adaptate Biotherapeutics Ltd. has raised $18 million in the second close of its series A, bringing the total for the round to $34 million and providing the means to accelerate development of a portfolio of antibodies targeting tissue-resident gamma delta T cells.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Adaptate Biotherapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Adaptate Biotherapeutics is included in 2 Expert Collections, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Adaptate Biotherapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Adaptate Biotherapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.